Summary & Overview
CPT 66770: Nonexcisional Destruction of Iris or Ciliary Body Lesion
CPT code 66770 covers nonexcisional destruction of a cyst or lesion in the iris or ciliary body using methods such as fine needle aspiration or laser. This ophthalmic procedure code is relevant nationally for ophthalmologists, surgical centers, and payers managing coverage of eye procedures where lesion ablation is preferred over excision. Understanding coding and clinical context for 66770 helps ensure accurate claim submission and consistent classification of minimally invasive ocular lesion treatments.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code represents, typical sites of service, and the clinical setting in which the procedure is performed. The publication also summarizes benchmarks and policy considerations that commonly affect reimbursement and coverage decisions for ophthalmic lesion destruction procedures, plus clinical context that clarifies when nonexcisional techniques are used compared with excisional surgery.
This summary is intended for national audiences including coding professionals, clinical administrators, and payer policy staff who need concise guidance on the clinical and billing identity of CPT code 66770 and what to expect when this procedure appears on a claim.
Billing Code Overview
CPT code 66770 describes a procedure in which the provider uses nonexcisional techniques to destroy a cyst or lesion in the iris or ciliary body of the eye. Examples of nonexcisional techniques include fine needle aspiration and laser beam applications. The procedure is performed when lesion destruction is indicated without surgical excision.
-
Service type: Ophthalmic lesion destruction using nonexcisional techniques
-
Typical site of service: Ambulatory surgical center or ophthalmology clinic with appropriate laser or minor procedure capabilities
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient presents to an ophthalmology clinic with a small, well-circumscribed cystic lesion of the iris discovered during a routine eye exam after complaints of intermittent visual disturbances and localized eye discomfort. Slit-lamp examination and anterior segment imaging confirm a benign-appearing iris cyst arising from the posterior pigment epithelium. After discussion of risks and benefits, the ophthalmologist elects a nonexcisional, destructive technique — for example, fine needle aspiration with adjunctive laser photocoagulation — to collapse and ablate the cyst while preserving surrounding iris tissue.
The clinical workflow includes pre-procedure informed consent, topical and/or local anesthesia, antiseptic preparation, use of an operating microscope or slit-lamp adaptor, performance of the nonexcisional destructive technique (aspiration, laser photocoagulation, or cryotherapy as appropriate), hemostasis and intraocular pressure assessment, immediate postoperative instructions, and short-interval follow-up to monitor for recurrence, inflammation, or intraocular pressure changes. Documentation includes indication, targeted lesion location (iris or ciliary body), technique used, laterality, any complications, and postoperative plan. Typical site of service is an ambulatory ophthalmic surgical suite, outpatient clinic procedure room, or same-day surgery center.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component |